US Patent Issued to Bayer, Bayer Pharma, The Broad Institute, Dana-Farber Cancer Institute on March 25 for "Dihydrooxadiazinones" (German, American Inventors)

ALEXANDRIA, Va., March 26 -- United States Patent no. 12,258,323, issued on March 25, was assigned to Bayer AG (Leverkusen, Germany), Bayer Pharma AG (Berlin), The Broad Institute Inc. (Cambridge, Mass.) and Dana-Farber Cancer Institute Inc. (Boston).

"Dihydrooxadiazinones" was invented by Manuel Ellermann (Berlin), Stefan Nikolaus Gradl (Berlin), Charlotte Christine Kopitz (Falkenesee, Germany), Martin Lange (Berlin), Adrian Tersteegen (Wuppertal, Germany), Philip Lienau (Berlin), Christa Hegele-Hartung (Mulheim an der Ruhr, Germany), Detlev Sulzle (Berlin), Timothy A. Lewis (Cambridge, Mass.), Heidi Greulich (Cambridge, Mass.), Xiaoyun Wu (Cambridge, Mass.), Matthew Meyerson (Boston) and Alex Burgin (Cambridge, Mass.).

According to the ...